Seyedkazemi Setareh

Adverum Biotechnologies, Inc. · CHIEF DEVELOPMENT OFFICER

Seyedkazemi Setareh is listed in filings as CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc.. This profile follows SEC Form 4 activity through Dec 10, 2025, including sale activity. Recent filings connect the profile to Adverum Biotechnologies, Inc. (ADVM). The current snapshot covers public activity from Aug 6, 2024 to Dec 10, 2025. Reported amounts are shown as $314.5K to $204.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.